Analysts review Pacira BioSciences Inc’s rating

Anna Perez

In a filing, Pacira BioSciences Inc revealed its Senior Vice President, Finance RIKER LAUREN unloaded Company’s shares for reported $34324.0 on Jan 05 ’26. In the deal valued at $24.24 per share,1,416 shares were sold. As a result of this transaction, RIKER LAUREN now holds 59,064 shares worth roughly $1.49 million.

Then, RIKER LAUREN bought 1,416 shares, generating $34,324 in total proceeds.

Before that, Cross Shawn sold 15,896 shares. Pacira BioSciences Inc shares valued at $397,877 were divested by the Chief Financial Officer at a price of $25.03 per share. As a result of the transaction, Cross Shawn now holds 56,250 shares, worth roughly $1.42 million.

Barclays initiated its Pacira BioSciences Inc [PCRX] rating to an Equal weight in a research note published on December 09, 2025; the price target was $27. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Truist also remained covering PCRX and has increased its forecast on July 25, 2025 with a “Buy” recommendation from previously “Hold” rating. Truist revised its rating on January 30, 2025. It rated PCRX as “a Hold” which previously was an “a Sell”.

Price Performance Review of PCRX

On Tuesday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock jump 0.84% to $25.31. Over the last five days, the stock has lost -2.88%. Pacira BioSciences Inc shares have risen nearly 38.08% since the year began. Nevertheless, the stocks have fallen -2.20% over the past one year. While a 52-week high of $27.64 was reached on 01/02/26, a 52-week low of $18.17 was recorded on 01/02/26.

Levels Of Support And Resistance For PCRX Stock

The 24-hour chart illustrates a support level at 24.89, which if violated will result in even more drops to 24.46. On the upside, there is a resistance level at 25.70. A further resistance level may holdings at 26.08.

How much short interest is there in Pacira BioSciences Inc?

A steep rise in short interest was recorded in Pacira BioSciences Inc stocks on 2025-12-15, growing by 67479.0 shares to a total of 7.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 7.28 million shares. There was a rise of 0.92%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.